VOLUME

• Research type

  Research Study

• Full title

  VOLUME: niVOLUMab in the rEal world in patients with squamous cell Carcinoma of the head & neck (scchn)

• IRAS ID

  277458

• Contact name

  Robert Metcalf

• Contact email

  robert.metcalf@christie.nhs.uk

• Sponsor organisation

  Bristol-Myers Squibb Research and Development

• Duration of Study in the UK

  0 years, 9 months, 5 days

• Research summary

  This is international observational study with a goal to collect data on treatment of recurrent/metastatic squamous cell carcinoma of head and neck. Main focus of this retrospective chart review study is to describe the utilization of Nivolumab among patients. It aims to seize the demographic and clinical characteristics of the patients with the above mentioned diagnose, the use patterns of Nivolumab among those patients, treatment pattern of those who discontinue Nivolumab and the effectiveness of the drug in the real-practice.

• REC name

  Yorkshire & The Humber - Leeds East Research Ethics Committee

• REC reference

  20/YH/0137

• Date of REC Opinion

  9 Jun 2020

• REC opinion

  Further Information Favourable Opinion